🎯
LATEST VERIFIED ALGORITHMIC EXECUTION
Quantitative engine captured a net profit of +19.26% on $OC in just 23h 32m.
JBI
$JBIO
🔒 US EquitiesJade Biosciences Inc
AVG HISTORICAL GAP
+0.89%
MAX GAP RECORD
+5.87%
🔒 PRO INSTITUTIONAL
AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡
SENTINEL HISTORICAL GAP VIEWER
// $JBIO
📊 1-YEAR TIMELINE (GAPS PLOTTED)
🔮 SIMULATE SETUP 🔒
GAP INSPECTION // PLAYBACK PROTOCOL
$JBIO
HISTORICAL GAP OCCURRENCE
Analyzing price jump between T-1 close and opening auction.
EVENT DATE—
GAP MAGNITUDE—
T-1 CLOSE—
OPEN PRICE—
AI DIRECTIONPRO ONLY 🔒
Bullish Opening Gap
Bearish Opening Gap
T-1 Close Baseline
CATALYSTS & GAP HISTORY
| Nov 12, 2026 Earnings Release 2026-11-12 (BEFORE OPEN (07:00)) | 🔮 UPCOMING 🔒 |
| Aug 10, 2026 Earnings Release 2026-08-10 (BEFORE OPEN) |
-0.18%
|
| May 13, 2026 Earnings Release 2026-05-13 (AFTER CLOSE) |
+0.92%
|
| Nov 12, 2025 Earnings Release 2025-11-12 (AFTER CLOSE) |
-1.50%
|
| Aug 13, 2025 Earnings Release 2025-08-13 (AFTER CLOSE) |
+5.87%
|
| May 14, 2025 Earnings Release 2025-05-14 (AFTER CLOSE) |
-0.66%
|
VOLATILITY & GAP BIAS
AVG GAP MOVE
1.8%
Bullish Gaps (1)
Bearish Gaps (1)
Neutral / Flat (3)
📖 Intelligence Summary
Jade Biosciences, Inc. is a biotechnology company which engages in the development of drugs for rare cardiopulmonary disease. It focuses on advancing AV-101, a dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hypertension. The company was founded by Benjamin T. Dake on July 27, 2018 and…
NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗